Breast Surgery Retractors Market Forecast Highlights Revenue Share Analysis Across Prime Geographies During the Forecast Period 2018 to 2028

Breast surgery retractors sales are poised to grow at a modest CAGR of 3.5% y-o-y in 2022, following an ambiguous year in 2022. Demand is majorly underpinned by growing number of plastic breast surgeries performed. Fact.MR, a global research & consulting firm, in the updated edition of the report, states a moderate growth rate during the period 2017-2025.

Surge in aesthetic awareness amid women and men for non-professional and professional reasons is stoking demand for several cosmetic and plastic procedures, consecutively generating demand for breast surgery retractors”, says Fact.MR.

For detailed insights on enhancing your product footprint, request for a sample here-

Will Aesthetic Procedures and Breast Cancer Continue to Revitalise Breast Surgery Retractors

The danger of breast cancer is directly related to age. Breast cancer is the most widespread invasive cancer amid women, impacting those more than 40 years of age. It is projected that more than 12% of women develop intrusive breast cancer in their lifetime. A huge female geriatric population, together with increasing awareness in relation to early prognosis and breast cancer, is projected to capitalize on the demand for breast surgery retractors.

Increment in aesthetic procedures, for instance, breast augmentation in addition to technological innovations such as lighted retractors and disposable retractors are further projected to encourage demand for breast surgery retractors. Technological progressions in the fields of interface and design are projected to provide better usability to surgeons.

Need more information about Report Methodology? Click here-

Will Plastic Surgeries Procedures Continue to Encourage Sales of Breast Surgery Retractors?

Plastic surgeries are forecasted to account for a huge chunk of the market share. Forecasts reflects a share of 2/5th of the entire breast surgery retractors industry. Growing need for breast reduction procedures, breast lift (mastopexy) as well as breast augmentation post-pregnancy are ascribed as significant drivers of the category. A static CAGR of around 4% is estimated in 2022 for the segment.

The lumpectomy category is trailing plastic surgery, and is projected to extend at a CAGR of around 3.5% in 2022. Non-hospitalization, rapid post-surgery recovery, and efficiency in prevention of breast cancer recurrence is likely to encourage the requirement for lumpectomy procedures. The segment is projected to account for around a quarter of the entire breast surgery retractors industry.

The US Continues to Remain Lucrative for Breast Surgery Retractors

The US is anticipated to capture around 40% of the overall market share owing to growing number of plastic surgery procedures as well as awareness in relation to aesthetic surgeries. While in Germany and the UK, the demand is surging for breast surgery retractors owing to the significance of aesthetics for non-professional and professional reasons.

Furthermore, China, Australia Japan & South Korea continues to reflect promising growth, due to increased prevalence of breast cancer and rising awareness amid people in relation to its treatment shall fuel market expansion. In addition, government initiatives to enhance medical facilities in developing nations such as India and a mushrooming pool of oncologists are further poised to augment the demand for breast surgery retractors.

Product Launches and Innovation Remain Significant Focus Areas: Fact.MR Survey

Breast Surgery Retractors market remains highly fragmented, with market player highly invested in proprietary technology to encourage sales. Fact.MR’s survey with thought leaders discovered that constant product launches and development along with geographical expansion, will remain a significant strategy for market players in 2022 & beyond. The updated edition of the report provides comprehensive coverage of the projected to remain the key strategies of market players. A few of the players profiled in the report are Medtronic, Integra Lifesciences Corporation, Hayden Medical, Inc., CooperSurgical Inc. and Invuity, Inc., Black & Black Surgical, Inc., B. Braun Melsungen AG, Medicare Surgical Products and OBP Medical Corporation. The updated edition also offers a detailed analysis of the COVID-19 impact on this market.

Get Access to the Full Report

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: [email protected]
Visit Our Website: